Press Release Archive
Press Releases
July 2021
07.22.2021 Partnerships Arvinas And Pfizer Announce Global Collaboration To Develop And Commercialize Protac® Protein Degrader Arv-471 07.22.2021 Medicines Partnerships Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471 07.21.2021 Partnerships Vaccines Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa 07.08.2021 Partnerships Collaboration Between Abbvie, Biogen And Pfizer Creates World's Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants To Human Health And Disease. 07.08.2021 Partnerships Research Vaccines Collaboration Between Abbvie, Biogen and Pfizer Creates World's Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease
June 2021
06.30.2021 Partnerships Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206 06.22.2021 Partnerships SVI announces collaboration with Pfizer 06.01.2021 Partnerships IMI SOPHIA PARTNERS WITH MACCABI’S RESEARCH AND INNOVATION CENTER (KSM), PFIZER, AND LAUSANNE UNIVERSITY HOSPITAL TO IMPROVE OBESITY TREATMENT
May 2021
05.27.2021 Partnerships RefleXion Announces New Additions to Board of Directors and Appoints Audit Committee Chair 05.26.2021 Partnerships The Foundation for the NIH Announces a New Research Initiative to Find Integrated Treatments Across Common Metabolic Diseases 05.19.2021 Partnerships Sosei Heptares announces that the third novel drug candidate from its multi-target drug discovery collaboration with Pfizer has started clinical trials
April 2021
04.29.2021 Partnerships Pfizer Ventures' Barbara Dalton Appointed as AMRA Medical's Newest Board Member
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.